newsfilter
← Latest News
ACCESS Newswire·

Ensysce Biosciences Secures Second Financing From 2025 Agreement to Advance Breakthrough Pain Programs

~Continued funding underscores investor confidence and supports advancement of abuse- and overdose-resistant analgesics~SAN DIEGO, CA / ACCESS Newswire / April 7, 2026 / Ensysce Biosciences, Inc. ("Ensysce"